Literature DB >> 715054

Prostaglandin E1-induced potentiation of the anticonvulsant action of phenobarbitone in the rat. Role of brain monoamines.

S K Bhattacharya, A K Sanyal.   

Abstract

Prostaglandin E1 (PGE1) significantly potentiated the anticonvulsant action of a sub-effective (EDO) dose of phenobarbitone, against maximal electroshock-induced seizures in the rat. PGE1-induced potentiation of phenobarbitone was significantly inhibited after pretreatment with drugs which are known to reduce brain serotonin activity, but was unaffected by drugs known to decrease brain catecholamine activity. Prostaglandin F2 alpha produced a moderate though statistically insignificant inhibition of PGE1 effect. The results suggest that PGE1-induced potentiation of phenobarbitone is not a direct effect but an indirect one, mediated through an increase in brain serotonin activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 715054     DOI: 10.1016/0161-4630(78)90042-3

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  5 in total

1.  The antinociceptive effect of intracerebroventricularly administered prostaglandin D2 in the rat.

Authors:  S K Bhattacharya
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Prostaglandin D2 inhibits pentylenetetrazole-induced convulsions in rats by a serotonin-mediated mechanism.

Authors:  S K Bhattacharya; S S Parmar
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

3.  Prostaglandins and central serotonergic activity in the rat.

Authors:  S K Bhattacharya
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

4.  Prostaglandin d2 induced potentiation of the anticonvulsant actions of phenobarbitone and phenytoin in rats. Role of serotonin.

Authors:  S K Bhattacharya; S S Parmar
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

5.  Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury.

Authors:  Alexander V Glushakov; Sean W Robbins; Connor L Bracy; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroinflammation       Date:  2013-10-30       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.